Table 2.
Univariate regression analysis for the association of TMAO with demographic characteristics between CHD or CHD-T2DM patients and control participants.
| Characteristic | CHD | CHD-T2DM | ||
|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | |
| Age | 1.066 (1.046–1.088) | 0.110 | 1.083 (0.963–1.203) | 0.124 |
| Male | 1.413 (0.911–2.190) | 0.122 | 1.383 (1.160–1.606) | 0.145 |
| HDL | 0.885 (0.436–1.795) | 0.735 | 0.276 (0.119–0.635) | 0.003 |
| LDL | 1.126 (0.827–1.534) | 0.450 | 0.958 (0.705–1.302) | 0.783 |
| Total cholesterol | 1.060 (0.867–1.295) | 0.569 | 0.915 (0.747–1.120) | 0.388 |
| Triglyceride | 1.073 (0.859–1.340) | 0.534 | 1.366 (1.088–1.716) | 0.007 |
| Lipoprotein (a) | 0.670 (0.263–1.709) | 0.402 | 0.253 (0.084–0.764) | 0.015 |
| Lipoprotein (b) | 1.438 (0.706–2.927) | 0.317 | 1.456 (0.768–2.759) | 0.249 |
| Blood glucose | 1.001 (0.865–1.158) | 0.993 | 2.388 (1.874–3.043) | 0.001 |
| hs-TnI | 1.737 (0.283–10.06) | 0.371 | 1.724 (0.001–8.053) | 0.013 |
| CKMB | 1.446 (1.044–2.002) | 0.026 | 1.867 (1.305–2.672) | 0.001 |
| TMAO | 3.621 (2.581–5.080) | 0.001 | 9.581 (5.451–16.840) | 0.001 |